HEPATOTOXICITY FOLLOWING NEVIRAPINE-CONTAINING REGIMENS IN HIV-1-INFECTED INDIVIDUALS
- 30 September 2002
- journal article
- Published by Elsevier in Pharmacological Research
- Vol. 46 (3), 295-300
- https://doi.org/10.1016/s1043-6618(02)00146-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapyAIDS, 2001
- Treatment of Primary Human Immunodeficiency Virus Type 1 Infection with Potent Antiretroviral Therapy Reduces Frequency of Rapid Progression to AIDSThe Journal of Infectious Diseases, 2001
- Adverse Effects Associated With Use of Nevirapine in HIV Postexposure Prophylaxis for 2 Health Care WorkersPublished by American Medical Association (AMA) ,2000
- Lactic Acidosis Associated with Stavudine Administration: A Report of Five CasesClinical Infectious Diseases, 2000
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapyNature Medicine, 1999
- Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort studyThe Lancet, 1999
- Adverse effects of reverse transcriptase inhibitorsAIDS, 1998
- Hepatitis B Virus InfectionNew England Journal of Medicine, 1997
- Hepatitis CAnnals of Internal Medicine, 1996